Hyperaldosteronism: Clinical Trials

3 trials for Hyperaldosteronism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 unknown. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Recruiting 2, Unknown 1
Phase 22Recruiting 2

Follow Hyperaldosteronism: new trials by email Literature Review of Hyperaldosteronism trials Research Report on Hyperaldosteronism

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate
[18F]CETO tracer, Dexamethasone oral, Adrenal vein sampling - Primary Aldosteronism
Phase 1 / Phase 2RecruitingUniversity Medical Center Groningen122024-11-062025-01-27
Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
Al18F-NOTA-Pentixafor PET/CT - Primary Aldosteronism, Primary Aldosteronism Due to Aldosterone Producing Adenoma
Phase 1 / Phase 2RecruitingPeking Union Medical College Hospital1502023-12-302025-02-26
Evaluation of Cerebral Small Vessel Disease in Patient With Primary Aldosteronism
Brain MRI - Evaluation of Cerebral Small Vessel Disease in Patient With Primary Aldosteronism
Phase 1UnknownNational Taiwan University Hospital602019-01-252019-01-30

Narrower conditions

Hypertension (1)

Broader conditions

Adrenal Gland Diseases (3)  ·  Adrenocortical Hyperfunction (3)  ·  Endocrine System Diseases (3)  ·  Cardiovascular Diseases (1)  ·  Vascular Diseases (1)

Interventions

Dexamethasone (1)

Sponsors

National Taiwan University Hospital (1)  ·  Peking Union Medical College Hospital (1)  ·  University Medical Center Groningen (1)

Countries

China (1)  ·  Netherlands (1)  ·  Taiwan (1)

Top investigators

Dr. M.N. Kerstens (1)  ·  Hsin-Hsi Tsai, MD (1)

Results publications

PMID 33859526, PMID 36074157

NIH funding

2023 (1)